June 8, 2021

M&A nel settore Life Sciences: uno sguardo multi-disciplinare

16 giugno 2021

Webinar 17:00 – 18:00

Gli aspetti legali delle operazioni di M&A nel Life Sciences, soprattutto nei settori farmaceutico e dei medical devices, richiedono un approccio sistematico e multidisciplinare da calibrare sulle specificità operative, economiche e regolamentari del settore e della singola target.

Nel corso del webinar, identificheremo criticità, trend e best practice, prendendo in considerazione le peculiarità del settore e il loro possibile impatto, sotto il profilo legale, su struttura, valutazione, contenuto ed esecuzione di una operazione di M&A e sui principali meccanismi contrattuali. Facendo riferimento a casi concreti, analizzeremo tematiche M&A connesse agli aspetti regolamentari e di compliance, di appalti pubblici e antitrust fino alle recenti novità in tema di “Golden Power”.

Il seminario si rivolge ad aziende del settore, investitori, banche d’affari e società di consulenza.

Interverranno:

ISCRIVITI

< Back to blog
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the life sciences and healthcare industry.
...
Read more
Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and venture capital transactions.

Close
September 21, 2022
Payback for medical devices: Decree quantifying the exceeding of the expenditure ceiling for medical devices at national and regional level for the years 2015, 2016, 2017 and 2018 published ...
September 1, 2022
The 2021 annual law for market and competition addressing, as to the healthcare sector, reimbursement of drugs, intermediate distribution, patent linkage and institutional accreditation of p...
July 19, 2022
Guidelines for the implementation of the Electronic Health Record (EHR) to ensure dissemination, uniformity and accessibility of the EHR at national level now published in the Official Gazet...
June 6, 2022
The National Coordination Centre for Ethics Committees published new draft agreements for conducting clinical trials on drugs and medical devices
April 27, 2022
EU Medical Device Coordination Group (MDCG) approves “Guidance” on the borderline between medical devices and medicinal products in order to support the uniform application of Regulation...
Search by...
Search
Follow us on
Follow us on